(Press-News.org) Researchers at University of California San Diego have published new guidelines that could help scientists significantly improve their results when quantifying the interactions between DNA and proteins. Understanding these interactions is critical to our understanding of human biology in general, and can also help scientists develop new treatments for a wide range of diseases, including many cancers.
The researchers focused on spike-in normalization, a widely-used molecular biology technique that helps ensure accurate and reliable results. Spike-in normalization involves adding a known quantity of chromatin (DNA and the associated proteins) to a sample before it is studied, which helps researchers account for variations between multiple samples being compared to one another. Spike-in normalization is particularly useful for comparing two conditions – such as to evaluate the impact of a drug (comparing treated vs untreated) or a mutation or a deletion in a key gene (comparing normal vs mutant).
By exploring publicly-available datasets that utilize spike-in normalization, the researchers were able to identify common scenarios where spike-in normalization is easily misused and in which building in additional quality control measures and other “guardrails” into the technique could improve results or avoid misinterpretation. By reanalyzing these data and conducting additional experiments of their own, the team was able to develop a list of nine key recommendations for researchers using spike-in normalization that could greatly increase the accuracy of their results. These measures include ensuring consistent quality control steps are taken, following best practices for computational analysis, and validating the results with other analysis techniques.
“Many studies utilize spike-in normalization, and our results call the biological conclusions drawn from this approach into question,” said senior author Alon Goren, Ph.D. “Our recommendations can help account for some of the pitfalls of spike-in normalization so we can still reap the benefits of this valuable technique.”
The study published on September 13, 2024 in Nature Biotechnology and was conducted by Lauren Patel and Yuwei Cao at UC San Diego and Eric Mendenhall, Ph.D. at HudsonAlpha Institute for Biotechnology. The study was co-led by Alon Goren, Ph.D., and Christopher Benner, Ph.D., both associate professors in the Department of Medicine at UC San Diego School of Medicine.
# # #
END
Research alert: Technique to study how proteins bind to DNA is easily misused; New study offers solution
2024-09-13
ELSE PRESS RELEASES FROM THIS DATE:
Edible insects show promise as sustainable nutritional source
2024-09-13
As the global population grows and traditional livestock production increasingly strains environmental resources, there is a rising interest in alternative protein sources. Edible insects, particularly grasshoppers, are abundant in regions like Cameroon and provide essential nutrients, including proteins, amino acids, and minerals vital for health and growth. Addressing these challenges calls for in-depth studies on the nutritional benefits of insects such as Ruspolia nitidula.
Conducted by the University of Dschang, Cameroon, and published (DOI: 10.26599/FSAP.2024.9240068) in the journal Food Science of ...
Machine learning could help reduce hospitalizations by nearly 30% during a pandemic, study finds
2024-09-13
A new study sheds light on a promising approach using machine learning to more effectively allocate medical treatments during a pandemic or any time there’s a shortage of therapeutics.
The findings, published today in JAMA Health Forum, found a significant reduction in expected hospitalizations when using machine learning to help distribute medication using the COVID-19 pandemic to test the model. The model proves to reduce hospitalizations relatively by about 27 percent compared to actual and observed care.
“During the pandemic, the healthcare system was at a breaking point and many health care facilities relied on a first-come, first-serve or a patient’s ...
E-cigarette brands are skirting the rules about health warning labels on Instagram
2024-09-13
Island breeze, blue lagoon, dew drop—these aren’t the names of scented candles on display at your local home goods store. They’re flavors of synthetic nicotine used in e-cigarettes, often advertised with neon-electric colors and bright lettering to make them look like boxes of candy or fruit juice. But underneath all the flair, a specific label written clearly in black text on a white background is required by law to be there: a warning that says the product contains nicotine and that nicotine is an addictive substance.
Even though health warnings need to be written on physical products sold in stores ...
Scientists discover potential cause of an enigmatic vascular disease primarily impacting women
2024-09-13
Mount Sinai researchers have identified a key driver of a blood vessel disorder known as fibromuscular dysplasia (FMD) which affects up to five percent of the adult population and can lead to high blood pressure, heart attack, or stroke.
In a study published September 13 in Nature Cardiovascular Research, the team said changes in the gene UBR4 played an important role as a key driver of FMD. They suggested the discovery could be an important step toward developing a therapeutic approach for the disorder.
“Although fibromuscular dysplasia was first recognized more than 80 years ago, until now ...
Stimulant, antidepressant, and opioid telehealth prescription trends between 2019 and 2022
2024-09-13
About The Study: From 2019 to 2022, overall prescription volumes for stimulant and antidepressant medications increased, while prescription volume for opioids decreased. Concurrently, the proportion of telehealth prescriptions climbed across medications, increasing by a factor of 188 in opioids and more than 20 for antidepressants. These findings align with existing research highlighting the shift toward telehealth and the rise in stimulant and opioid telehealth prescribing during the pandemic. While in-person prescribing remains the most common, increasing telehealth ...
One-year weight reduction with semaglutide or liraglutide in clinical practice
2024-09-13
About The Study: In this retrospective cohort study of 3,389 patients with obesity, weight reduction at 1 year was associated with the medication’s active agent, its dosage, treatment indication, persistent medication coverage, and patient sex. Future research should focus on identifying the reasons for discontinuation of medication use and interventions aimed at improving long-term persistent coverage.
Corresponding Author: To contact the corresponding author, Hamlet Gasoyan, PhD, email gasoyah@ccf.org.
To access the embargoed study: Visit our For The Media ...
Adolescents and young adults’ sources of contraceptive information
2024-09-13
About The Study: This study’s results suggest discrepancies between preferred and actual sources of contraceptive information for assigned female at birth adolescents and young adults in the U.S. Findings underscore the role of clinicians in supporting informed contraceptive decision-making among adolescents and young adults. Clinicians were the most commonly preferred source, and receiving information from them was associated with having sufficient information to choose a contraceptive method; however, clinicians were the source with the largest discrepancy between preferred and actual use.
Corresponding Author: To contact the corresponding author, ...
Health warnings on Instagram advertisements for synthetic nicotine e-cigarettes and engagement
2024-09-13
About The Study: In this cross-sectional study of synthetic nicotine brand Instagram accounts, 87% of sampled posts did not adhere to FDA health warning requirements in tobacco promotions. Enforcement of FDA compliant health warnings on social media may reduce youth engagement with tobacco marketing.
Corresponding Author: To contact the corresponding author, Traci Hong, PhD, email tjhong@bu.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.34434)
Editor’s Note: Please see the article for additional information, including ...
Cleveland Clinic study identifies key factors that can impact long-term weight loss in patients with obesity who were prescribed GLP-1 RA medications
2024-09-13
UNDER EMBARGO Friday, September 13, 2024, 11 a.m. ET, CLEVELAND: A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The study was published in JAMA Network Open.
“In patients with obesity who were prescribed semaglutide or liraglutide, we found that long-term weight reduction varied significantly based on the medication’s active agent, treatment indication, dosage and persistence with the medication,” said Hamlet Gasoyan, Ph.D., lead author of the study ...
Neoself-antigens induce autoimmunity in lupus
2024-09-13
Osaka, Japan – Autoimmune diseases are widespread and notoriously difficult to treat. In part, this is because why the immune system attacks its own tissues in patients with these conditions remains poorly understood.
In a study recently published in Cell, researchers from Osaka University have revealed that the body’s own proteins with unusual structure trigger immune cells to unleash a wave of inflammation that leads to autoimmunity.
Autoimmune diseases develop when the body’s immune system mistakenly attacks its own tissues instead of fighting off foreign invaders like bacteria or viruses. However, it has long been a mystery why this happens, as ...